How Africa’s Brain Week Is Changing Neurological Healthcare from Grassroots to Top Policy

Brain Week Conference opened with urgency and hope, where neurological health was placed, not only in hospitals and lecture rooms, but also in communities, families, and everyday life. Spanning rural Rwanda, under-served areas in Sudan, and other parts, experts and activists united under one compelling idea: brain health in Africa is accessible, inclusive, and relevant, especially in Africa.

Opening Friday’s sessions was a thought-provoking presentation by Dr. Vincent Hategekimana on the challenges that people living with epilepsy face when accessing health care within Kisaro and Buyoga sectors in Rulindo District, Rwanda. From his working experience and research within these communities, Dr. Hategekimana revealed how poverty and long distances to health centers have been impeding the diagnosis and treatment of people living with epilepsy. Other hindrances include the associated stigma with epilepsy.

“Epilepsy is not only a medical condition here; it is a social sentence for many,” Dr. Hategekimana said. “When people fear being labeled or excluded, they delay seeking care, and that delay costs lives, education, and dignity.”

His address recognized, among other issues, that fighting issues relating to epilepsy will demand more than medical interventions alone.

That reality was powerfully embodied in the life story of Chantal Kanyabutembo, whose testimony transformed statistics into human truth.

At just 11 years old, epilepsy abruptly disrupted her education and social life. Misunderstood and stigmatized, she was pushed to the margins of both school and society. For years, her condition was mismanaged, reinforcing fear and exclusion.

“Epilepsy took away my confidence before it took away my education,” Chantal shared. “I was seen as incapable, not because of my abilities, but because of ignorance.”

Everything changed when she finally received a proper diagnosis and consistent treatment. With medical stability came a rebirth of self-belief. Chantal returned to education, reclaimed her voice, and began envisioning a future once denied to her. Today, she stands as one of Rwanda’s leading disability rights advocates.

As the CEO of GECO Rwanda, Chantal now co-leads a cooperative that supports people living with epilepsy and other neurological conditions. The initiative focuses on combating stigma, improving access to healthcare, and creating pathways to education and employment.

“I decided that my pain would not end with me,” she said. “Lived experience is not a weakness it is a tool for change when you use it to uplift others.”

The conversation then shifted to stroke care, where Dr. Mark Nyanzu challenged the tendency to measure success solely by surgical or acute clinical outcomes. He stressed that recovery does not end when a patient leaves the operating room.

“A successful surgery is only the beginning,” Dr. Nyanzu emphasized. “Real recovery depends on rehabilitation, psychological support, and the involvement of families and communities.”

He highlighted that in many African settings, stroke survivors return home without access to physiotherapy, counseling, or structured follow-up, leading to preventable disability and relapse. Investing in post-stroke care systems, he argued, is as critical as investing in advanced neurosurgical capacity.

Adding a regional perspective, Professor Osheik Abu’Asha shared Sudan’s innovative approach to neurological outreach, particularly in hard-to-reach and conflict-affected communities. Through mobile neurology caravans, Sudanese health teams are bringing services directly to the people raising awareness, improving early stroke detection, and strengthening referral systems.

“When hospitals cannot reach the people, medicine must move,” Professor Abu’Asha said. “Our caravans are not just clinics on wheels; they are platforms for trust, education, and early intervention.”

His presentation demonstrated how low-cost, context-sensitive innovations can significantly expand access to neurological care, even in resource-constrained environments.

The day concluded with a high-level academic contribution from Professor Tahir Obeid, FROP, FAAN, Professor of Neurology at UMST, who delivered an incisive presentation during the 4th African MENA Brain Week Conference in Kigali 2026 on the Challenges of Managing a First Unprovoked Seizure in African Countries.

Professor Obeid outlined critical gaps facing the continent, including delayed diagnosis, limited access to EEG and neuroimaging, treatment interruptions, persistent stigma, and systemic health workforce shortages.

“A first seizure is not just a clinical event it is a defining moment,” he explained. “If we fail at that moment, we set patients on a path of uncertainty, fear, and avoidable disability.”

He strongly advocated for context-appropriate clinical guidelines, capacity building for frontline health workers, and policies that ensure equitable neurological care across Africa. His call resonated deeply with both clinicians and policymakers in the room.

From community-level advocacy to continental policy reform, the Brain Week Conference demonstrated that sustainable neurological care in Africa must be inclusive, compassionate, and rooted in real lives.

As voices like Chantal’s rise alongside experts like Dr. Hategekimana, Dr. Nyanzu, Professor Abu’Asha, and Professor Obeid, Africa’s neurological future is being reshaped not only by science, but by courage, collaboration, and conviction.